Medicare Enrolled
Dr. Rahul Chopra, M.D.
Radiology - Diagnostic · Melbourne, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chopra from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chopra? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chopra
Dr. Rahul Chopra is a radiology - diagnostic in Melbourne, FL, with 17 years in practice. Based on federal Medicare data, Dr. Chopra performed 10,089 Medicare services across 2,136 unique beneficiaries.
Between the years covered by Open Payments, Dr. Chopra received a total of $11,984 from 79 pharmaceutical and/or device companies across 333 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiology - diagnostic. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chopra is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice▲ Top 7% volume in FL$ $11,984 industry payments
Medicare Practice Summary
Medicare Utilization ↗10,089
Medicare services
Top 7% in FL for radiology - diagnostic
2,136
Unique beneficiaries
$130
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~593 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) | 3,081 | $0 | $3 |
| Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | 1,757 | $58 | $637 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 1,523 | $274 | $2,582 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | 807 | $179 | $529 |
| Continuing radiation therapy consultation per week | 534 | $67 | $333 |
| Radiation treatment management, 5 treatment sessions | 467 | $153 | $1,036 |
| Calculation of radiation therapy dose | 377 | $51 | $354 |
| Design and construction of complex radiation treatment device | 215 | $94 | $689 |
| CT guidance for radiation therapy | 177 | $94 | $595 |
| Complex radiation therapy planning | 131 | $135 | $992 |
| Office visit, established patient (20-29 min) | 103 | $66 | $180 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 102 | $409 | $1,370 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 97 | $1,192 | $4,120 |
| New patient office visit (45-59 min) | 96 | $129 | $420 |
| High precision radiation therapy planning | 88 | $1,430 | $6,820 |
| Design and construction of radiation treatment device for high precision radiation therapy | 88 | $366 | $2,563 |
| Cranial lesion surgery using radiation over multiple sessions | 81 | $771 | $7,971 |
| Special radiation therapy planning | 56 | $52 | $269 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 54 | $346 | $1,165 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 41 | $209 | $631 |
| Office visit, established patient (30-39 min) | 39 | $99 | $224 |
| Ct scan of chest with contrast | 35 | $91 | $1,005 |
| Special radiation treatment | 29 | $111 | $1,741 |
| CT scan of abdomen and pelvis with contrast | 27 | $241 | $1,400 |
| Management of cranial lesion surgery using radiation over multiple sessions | 23 | $517 | $3,504 |
| 3d radiation therapy planning | 21 | $361 | $4,247 |
| New patient office visit (30-44 min) | 15 | $72 | $230 |
| Office visit, established patient (10-19 min) | 14 | $40 | $90 |
| Special medical radiation therapy consultation | 11 | $108 | $390 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.0% high complexity
80.2% medium
18.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,984
Total received (2018-2024)
Avg $1,712/year across 7 years
Top 10% in FL for radiology - diagnostic
79
Companies
333
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,884 (82.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,100 (17.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$4,335
2023$1,847
2022$1,160
2021$1,426
2020$778
2019$1,197
2018$1,241
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$2,595
Novocure Inc.
$892
Novartis Pharmaceuticals Corporation
$554
E.R. Squibb & Sons, L.L.C.
$500
Merck Sharp & Dohme LLC
$496
Ipsen Biopharmaceuticals, Inc
$454
Incyte Corporation
$368
Janssen Biotech, Inc.
$363
Eisai Inc.
$332
PFIZER INC.
$279
Pharmacyclics LLC, An AbbVie Company
$252
Janssen Scientific Affairs, LLC
$239
Bayer HealthCare Pharmaceuticals Inc.
$211
Regeneron Healthcare Solutions, Inc.
$203
Astellas Pharma US Inc
$191
Amgen Inc.
$181
Bayer Healthcare Pharmaceuticals Inc.
$167
ABBVIE INC.
$167
Lilly USA, LLC
$156
Daiichi Sankyo Inc.
$155
Myovant Sciences Inc.
$155
TOLMAR Pharmaceuticals, Inc.
$134
Seattle Genetics, Inc.
$130
Advanced Accelerator Applications
$128
BeiGene USA, Inc.
$122
TESARO, Inc.
$122
SpringWorks Therapeutics, Inc.
$115
Takeda Pharmaceuticals U.S.A., Inc.
$115
Stemline Therapeutics Inc.
$110
Aveo Pharmaceuticals, Inc.
$109
Boston Scientific Corporation
$109
GENZYME CORPORATION
$108
Seagen Inc.
$103
Kyowa Kirin, Inc.
$93
Augmenix, Inc.
$89
G1 Therapeutics, Inc.
$88
Merck Sharp & Dohme Corporation
$84
Myriad Genetic Laboratories, Inc.
$76
Pharmacyclics LLC, an AbbVie Company
$76
JAZZ PHARMACEUTICALS INC.
$75
Celgene Corporation
$70
Karyopharm Therapeutics Inc.
$65
Ambu Inc.
$56
ARRAY BIOPHARMA INC
$51
TerSera Therapeutics LLC
$50
Gilead Sciences, Inc.
$49
SERVIER PHARMACEUTICALS LLC
$47
Heron Therapeutics, Inc.
$44
Jazz Pharmaceuticals Inc.
$41
Sumitomo Pharma America, Inc.
$40
Dendreon Pharmaceuticals LLC
$34
PUMA BIOTECHNOLOGY, INC.
$33
SOBI, INC
$29
Sun Pharmaceutical Industries Inc.
$25
EMD Serono, Inc.
$25
Servier Pharmaceuticals LLC
$25
EISAI INC.
$24
Medtronic USA, Inc.
$23
Mirati Therapeutics, Inc.
$22
Genentech USA, Inc.
$21
Teleflex LLC
$21
MorphoSys, US Inc.
$20
Acrotech Biopharma LLC
$20
Genmab U.S., Inc.
$20
GlaxoSmithKline, LLC.
$19
Emmaus Medical, Inc.
$18
EUSA Pharma (US) LLC
$18
Mylan Institutional Inc.
$18
Foundation Medicine, Inc.
$17
Alexion Pharmaceuticals, Inc.
$17
Tolmar, Inc.
$17
Acceleron Pharma, Inc.
$17
TAIHO ONCOLOGY, INC.
$16
Agios Pharmaceuticals, Inc.
$16
Verity Pharmaceuticals Inc.
$15
Helsinn Therapeutics (U.S.), Inc.
$13
Sobi, Inc
$13
Blueprint Medicines Corporation
$12
Octapharma USA, Inc.
$12
Top 3 companies account for 33.7% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AKYNZEO · AMS · ASPARLAS · AYVAKIT · Abraxane · Alecensa · Aliqopa · BELEODAQ · BRAFTOVI · BRUKINSA · Bavencio · CALQUENCE · CINVANTI · COSELA · CYRAMZA · DARZALEX · DOPTELET · ELAHERE · ELIGARD · ENJAYMO · EPKINLY · ERLEADA · Endari · Enhertu · Epkinly · Erleada · FOTIVDA · FOUNDATIONONE · FRUZAQLA · FULPHILA · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · Imbruvica · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MYRISK · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · ODOMZO · OGSIVEO · OPDIVO · ORGOVYX · OSTEOCOOL RF ABLATION · Oncology · Optune · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROVENGE · Prolaris · Reblozyl · Revlimid · SANCUSO · SANDOSTATIN LAR · SOMATULINE DEPOT · Somatuline Depot · SpaceOAR · Stivarga · Sylvant · TAGRISSO · TALZENNA · TIBSOVO · TUKYSA · Tazverik · Trelstar · ULTOMIRIS · VENCLEXTA · VERZENIO · WILATE · XGEVA · XPOVIO · XTANDI · Xofigo · Xospata · Xtandi · ZEJULA · ZEPZELCA · Zoladex · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (82%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for radiology - diagnostic in FL.
Equivalent to $119 per 100 Medicare services performed
Geographic Context
Radiology - Diagnostics within 10 mi
10
Per 100K population
1.6
County median income
$75,817
Nearest hospital
HOLMES REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Chopra is a mixed practice specialist, with above-average Medicare volume (top 7% in FL), and high industry engagement (low-engagement, top 10%), with 17 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Chopra experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Chopra performed 3,081 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chopra receive payments from pharmaceutical companies?
Yes. Dr. Chopra received a total of $11,984 from 79 companies across 333 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chopra's costs compare to other radiology - diagnostics in Melbourne?
Dr. Chopra's average Medicare payment per service is $130. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chopra) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Radiology - Diagnostics in Melbourne
Browse radiology - diagnostics in Melbourne ranked by procedure volume and transparency data.
Highest volume
Top Radiology - Diagnostics in FL
Radiology - Diagnostics ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Radiology - Diagnostics in FL
Which FL radiology - diagnostics receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novocure Inc. Payments to Doctors
See all physicians who received payments from Novocure Inc..
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology